continuous glucose monitor inventory. That tape became really important to our sales and our impact.”
ExpressionMed sells its products on its website, as well as on Amazon (NASDAQ: [[ticker:AMZN]]) and diabetes-focused retailers like Pimp My Diabetes and Zuckerschmuck, Sharkus says.
The startup’s revenues in 2017 were a little over $60,000, she says, and ExpressionMed projects that figure will climb to more than $200,000 this year.
The company had also received about $105,000 in grant funding—largely from its success in pitch competitions—prior to Sharkus being named a Thiel Fellow. She says she’s the sole owner of ExpressionMed.
Earlier this year, it graduated from gBETA Medtech, a seven-week entrepreneurial training program held in the Twin Cities. The program, which does not provide participating companies with cash or take equity stakes in them, is organized by the Wisconsin-based startup accelerator Gener8tor.
“Working with Meghan during the program was always high-energy—you don’t need a midday coffee if you’re meeting with the ExpressionMed team,” says Adam Choe, director of gBETA Medtech. “The Thiel Fellowship will allow ExpressionMed to have the full attention of Meghan and based on the seven weeks we got to spend [together], we know there are big milestones on the horizon.”
